SBIR/STTR Research Award

Diametrically Patterned Dural Graft for Enhanced Dura Mater Regeneration

Award identifier a4c5352781d2731025b06065d6665fa28d3f4f7e9c54171419f659d14aa80f7dAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,351,152

Program and phase

SBIR · Phase II

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NANONERVE, INC.
Proposal award date
2013-09-16
Contract end date
2016-08-31
UEI
Not reported
Solicitation number
PA12-088
Topic code
NINDS

Research abstract

DESCRIPTION provided by applicant NanoNerve is developing a novel diametrically patterned nanofibrous dural substitute for rapid dura mater regeneration following neurosurgical procedures In the US alone neurosurgical procedures are performed annually that require patching of the dura mater to prevent leakage infection and neural damage Currently available dural substitutes include xenogenic collagen matrices and permanent synthetic devices Xenogeneic collagen matrices have significant disadvantages including low mechanical strength low suturability and high cost and disease transmission risks The permanent synthetic devices also suffer from major disadvantages including resistance to dura mater regeneration need for extensive suturing during implantation and higher leakage rates The overall goal of the project is FDA K clearance and commercialization of a highly versatile diametrically patterned nanofibrous dural substitute NanoNerve is utilizing its patent pending electrospinning technology to diametrically pattern nanofibers for rapidly regenerating dural tissue from the entire periphery of the defect toward the center NanoNerveandapos s synthetic bioresorbable nanofibrous dural substituteandapos s ultra thin profile and high mechanical strength will enable it to become the first synthetic dural substitute capable of sutured and suture free implantation This Phase II project will continue development of the diametrically patterned nanofibrous dural substitute by performing biocompatibility safety stability and long term in viv implantation studies Upon achievement of Phase II milestones NanoNerve will file an FDA IDE application for human clinical testing and eventually an FDA k for market clearance PUBLIC HEALTH RELEVANCE Over neurosurgical procedures are performed annually that require grafting of the dura mater to prevent fluid leakage infection and neural tissue damage Currently available dural substitutes have major limitations including incomplete dural repair low mechanical strength and high leakage rate complications This phase II study will enable development of a strong versatile and diametrically patterned nanofibrous dural substitute for rapid and effective dura mater regeneration

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.